Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, July 8, 2026

Inflammation Forces Brain Stem Cells to Halt Neurogenesis

 How EXACTLY  will your competent? doctor prevent this inflammation? You need neurogenesis to recover according to your doctor; SO THERE BETTER BE A SOLUTION!

Inflammation Forces Brain Stem Cells to Halt Neurogenesis

Summary: A new study demonstrated that introducing inflammatory signaling molecules directly into human hippocampal stem cells brings new neuron production to a dead stop. Instead of simply dying or becoming damaged, the brain’s neural stem cells actively abandon their regenerative responsibilities, transforming into an “immune alert” state that actively fuels localized neuroinflammation.

Key Facts

  • The Cytokine Intrusion: The team analyzed the behavior of cytokines, specialized chemical signaling proteins released by the body during immune threats, such as severe viral infections. While transient cytokine spikes help clear out acute sickness, sustained high levels are a classic hallmark of devastating chronic inflammation.
  • The TNF-α Standstill: When researchers exposed human hippocampal stem cells to a specific pro-inflammatory cytokine called Tumor Necrosis Factor alpha (TNF-α), the cellular birth pipeline froze. The stem cells completely ceased differentiating into mature, functional neurons.
  • The “Immune Alert” Takeover: To the shock of the investigators, the stem cells weren’t merely passive casualties of chemical stress. Instead, they actively assumed a hostile, immune-supportive behavior, pumping out high-alert chemical signals designed to recruit inflammatory T cells straight into the brain’s delicate learning centers.
  • The Type I Interferon Accidental Route: By mapping the molecular cascade, the team identified a highly unexpected signaling pathway driving this cellular hijack: Type I Interferons. These molecules are traditionally recognized as the body’s first-line defensive shield against viral replication, but here they inadvertently act as the executioner of neurogenesis.
  • Reversing the Damage: In a major therapeutic triumph, the KCL team introduced an existing therapeutic antibody designed to block Type I Interferon signaling. The intervention successfully reversed the damage, shutting down the recruitment of inflammatory T cells and completely restoring the stem cells’ capacity to regenerate fresh, healthy neurons.
  • A Diagnostic Bridge for Long-Syndromes: This discovery provides an invaluable clinical explanation for the persistent cognitive impairments, “brain fog,” and mood disorders reported by patients recovering from aggressive viral infections, navigating major depressive disorders, or entering the early stages of Alzheimer’s disease.

Source: King’s College London

The King’s College London study, published in Nature Communications, offers insight into how long-term inflammation may contribute to cognitive decline in disorders such as Alzheimer’s disease, ageing, depression, and the lingering neurological effects of viral infections.

The scientists discovered that adding a molecule, that is involved in the inflammatory response, to stem cells from the hippocampus prevents the development of new neurons. The formation of new neurons in this region, known as hippocampal neurogenesis, is essential for learning, memory and mood regulation. It is one of the few parts of the human brain where new neurons are made in adults. Altered adult hippocampal neurogenesis is associated with ageing, neurodegeneration, and mood disorders such as depression.

No comments:

Post a Comment